These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25169936)

  • 1. Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension.
    Yaoita N; Shirakawa R; Fukumoto Y; Sugimura K; Miyata S; Miura Y; Nochioka K; Miura M; Tatebe S; Aoki T; Yamamoto S; Satoh K; Kimura T; Shimokawa H; Horiuchi H
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2486-94. PubMed ID: 25169936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The oxygen kinetic effect of inhaled iloprost in pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension].
    Cui N; Yang YH; Xie WM; Ma ZH; Luo L; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):522-6. PubMed ID: 19954007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inefficient exercise gas exchange identifies pulmonary hypertension in chronic thromboembolic obstruction following pulmonary embolism.
    McCabe C; Deboeck G; Harvey I; Ross RM; Gopalan D; Screaton N; Pepke-Zaba J
    Thromb Res; 2013; 132(6):659-65. PubMed ID: 24157082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic.
    Miniati M; Fiorillo C; Becatti M; Monti S; Bottai M; Marini C; Grifoni E; Formichi B; Bauleo C; Arcangeli C; Poli D; Nassi PA; Abbate R; Prisco D
    Am J Respir Crit Care Med; 2010 May; 181(9):992-6. PubMed ID: 20075386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet protease-activated receptor 1 and membrane expression of P-selectin in pulmonary arterial hypertension.
    Maeda NY; Carvalho JH; Otake AH; Mesquita SM; Bydlowski SP; Lopes AA
    Thromb Res; 2010 Jan; 125(1):38-43. PubMed ID: 19447475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension.
    Yaoita N; Satoh K; Satoh T; Sugimura K; Tatebe S; Yamamoto S; Aoki T; Miura M; Miyata S; Kawamura T; Horiuchi H; Fukumoto Y; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1293-301. PubMed ID: 27102961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of cardiopulmonary exercise testing in patients with chronic thromboembolic pulmonary hypertension].
    Zhao ZH; Liu ZH; Gu Q; Luo Q; Zhao Q; Xiong CM; Ni XH
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1687-90. PubMed ID: 24124672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties.
    Ulrich S; Fischler M; Speich R; Popov V; Maggiorini M
    Chest; 2006 Sep; 130(3):841-6. PubMed ID: 16963684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.
    Sobolewska B; Grimmel C; Gatsiou A; Sopova K; Klein J; Biedermann T; Stellos K; Ziemssen F
    Ophthalmologica; 2015; 234(4):195-210. PubMed ID: 26305017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic changes by breathing hypoxic and hyperoxic gas mixtures in pulmonary arterial and chronic thromboembolic pulmonary hypertension.
    Groth A; Saxer S; Bader PR; Lichtblau M; Furian M; Schneider SR; Schwarz EI; Bloch KE; Ulrich S
    Int J Cardiol; 2018 Nov; 270():262-267. PubMed ID: 29891241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?
    Smits AJ; Isebia K; Combee-Duffy C; van der Wal S; Nossent EJ; Boonstra A; Vonk-Noordegraaf A; Bogaard HJ; Serné EH
    Sci Rep; 2024 Aug; 14(1):19467. PubMed ID: 39174569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.
    Godinas L; Sattler C; Lau EM; Jaïs X; Taniguchi Y; Jevnikar M; Weatherald J; Sitbon O; Savale L; Montani D; Simonneau G; Humbert M; Laveneziana P; Garcia G
    J Heart Lung Transplant; 2017 Nov; 36(11):1234-1242. PubMed ID: 28666570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension.
    Bonderman D; Turecek PL; Jakowitsch J; Weltermann A; Adlbrecht C; Schneider B; Kneussl M; Rubin LJ; Kyrle PA; Klepetko W; Maurer G; Lang IM
    Thromb Haemost; 2003 Sep; 90(3):372-6. PubMed ID: 12958604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differences in hemodynamics of thromboembolic and primary pulmonary hypertension].
    Polanowski T; Kurzyna M; Kuca P; Tomkowski W; Fijałkowska A; Kober J; Torbicki A
    Pol Arch Med Wewn; 2000 Nov; 104(5):741-5. PubMed ID: 11434085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive screening using ventilatory gas analysis to distinguish between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
    Akizuki M; Sugimura K; Aoki T; Kakihana T; Tatebe S; Yamamoto S; Sato H; Satoh K; Shimokawa H; Kohzuki M
    Respirology; 2020 Apr; 25(4):427-434. PubMed ID: 31261445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study.
    Vizza CD; Badagliacca R; Sciomer S; Poscia R; Battagliese A; Schina M; Agati L; Fedele F
    Cardiology; 2006; 106(3):168-73. PubMed ID: 16645271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Appl Health Econ Health Policy; 2011 Nov; 9(6):377-87. PubMed ID: 21888449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.
    Khirfan G; Tejwani V; Wang X; Li M; DiDonato J; Dweik RA; Smedira N; Heresi GA
    PLoS One; 2018; 13(5):e0197700. PubMed ID: 29813091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.